Patient groups invest in genetic databases to speed drug development

Tens of millions of dollars are being invested by nonprofit patient groups, including the Leukemia & Lymphoma Society, the Multiple Myeloma Research Foundation and the Michael J. Fox Foundation, to create genetic databases in a push to support clinical studies and accelerate drug development. Drugmakers and scholars can analyze genetic mutations using material from these databases, which are created to gather DNA and other data from patients with hard-to-treat diseases. With the aid of these databases, patients familiar with their own genetic mutations can find information about clinical studies.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL